Stephanie Bayers, MD
Dermatology · Hinsdale, ILNPI 1346668902
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,057 and has fallen 75.7% since, to $499 in 2025.
Across 292 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$998
- Sun Pharmaceutical Industries Inc.$604
- Galderma Laboratories, L.p.$591
- Lilly USA, LLC$407
- Pfizer$388
- Mayne Pharma Commercial LLC$365
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,39399%
- Education$971%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $998 |
| Sun Pharmaceutical Industries Inc. | 34 | $604 |
| Galderma Laboratories, L.p. | 28 | $591 |
| Lilly USA, LLC | 20 | $407 |
| Pfizer | 24 | $388 |
| Mayne Pharma Commercial LLC | 11 | $365 |
| Regeneron Healthcare Solutions, Inc. | 14 | $359 |
| Sanofi | 15 | $350 |
| Prugen, Inc. Pharmaceuticals | 2 | $329 |
| Johnson & Johnson | 9 | $276 |
| Amgen | 8 | $196 |
| Novartis | 9 | $192 |
| Bristol Myers Squibb | 8 | $158 |
| Incyte Corporation | 7 | $145 |
| UCB, Inc. | 4 | $144 |
| LEO Pharma Inc. | 8 | $141 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $123 |
| Revance Therapeutics, Inc. | 1 | $92 |
| Encore Dermatology Inc. | 3 | $53 |
| EPI Health, LLC | 3 | $53 |
| Almirall LLC | 3 | $53 |
| Dermavant Sciences, Inc. | 3 | $52 |
| VYNE Pharmaceuticals Inc. | 2 | $50 |
| Dermira, Inc. | 2 | $48 |
| Misonix Inc | 1 | $48 |
| Smith+Nephew | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Glenmark Therapeutics Inc. | 3 | $32 |
| Mission Pharmacal Company | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $24 |
| Mentor Worldwide LLC | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| DUSA Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Journey Medical Corporation | 1 | $13 |
How this compares
$6,490 in reported general payments places this provider in the 70th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 27 | $424 |
| Ketoconazole | 38 | $386 |
| Doxycycline Hyclate | 12 | $307 |
| Hydrocortisone | 28 | $130 |
| Mupirocin | 15 | $122 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hinsdale
- Alix CharlesHinsdale$47K
- Matthew HarrisHinsdale$31K
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.